Peptide research glossary.

An N-terminal modification that adds an acetyl group; documented alongside the peptide sequence because it changes mass and stability behaviour in research models.

Adrenocorticotropic hormone, a peptide hormone whose sequence has been used as a starting point for synthetic analogues studied in neurobiology research.

A cytoskeletal protein involved in cell shape and movement; studied in models examining peptide interactions with cellular structural systems.

A compound that binds to a receptor and triggers a response associated with that receptor's pathway in a research model.

A measured sub-portion of a larger sample prepared for a specific assay or storage condition, recorded against batch documentation.

A C-terminal modification that converts the carboxyl group to an amide; documented alongside the peptide sequence because it changes mass and stability behaviour in research models.

An organic molecule containing both amine and carboxylic acid groups; amino acids are the building blocks linked by peptide bonds to form peptides and proteins.

A compound structurally related to a reference molecule, often modified to study how specific changes affect behaviour in a research context.

The biological process by which new blood vessels form from existing vasculature; described as a pathway endpoint in some preclinical peptide research models.

A compound that binds to a receptor without triggering its associated response, typically blocking other ligands from binding in the same model.

A laboratory procedure used to measure or detect the presence, quantity, or activity of a target compound or biological response.

A document describing the production, identification, and analytical context of a specific batch of research material.

The proportion of a compound that reaches systemic circulation in a given model. Used as a research descriptor in pharmacokinetic study contexts.

The end of a peptide chain that carries a free carboxyl group; conventionally written on the right when sequences are reported.

A controlled environment in which cells are maintained outside their original organism to support experimental observation.

The directed movement of cells, observed in laboratory assays as one endpoint when characterising peptide-associated cellular behaviour.

A summary document referencing analytical observations such as identity confirmation and purity description for a specific batch.

A documented record of who has handled a research sample and under what conditions, supporting traceability across assays.

Common abbreviation for certificate of analysis.

The study of compounds in which a central atom or ion is bound to surrounding molecules or ions; relevant when describing metal-binding peptide complexes.

Cyclic adenosine monophosphate (cAMP), an intracellular second messenger referenced in receptor signalling research, including functional assays of GHRH receptor activation in laboratory models.

A unit of molecular mass equal to one twelfth the mass of a carbon-12 atom; commonly abbreviated Da and used when reporting peptide molecular weight.

The series of molecular events triggered after a receptor or upstream component is engaged, often used when describing pathway observations in laboratory models.

Originating from within an organism; used to describe peptides naturally produced in biological systems, in contrast to synthetic analogues.

Research conducted on tissue or cells removed from an organism and studied under controlled laboratory conditions.

The network of proteins and other molecules surrounding cells that provides structural and biochemical context, frequently referenced in matrix-oriented peptide studies.

A shorter peptide derived from, or modelled on, a region of a longer parent sequence and studied separately in research models.

Repeated cycling of a sample between frozen and thawed states; tracked because it can affect peptide integrity during research handling.

The process by which information encoded in a gene produces a functional product such as RNA or protein; commonly measured as a marker in peptide research models.

Growth hormone releasing hormone. Studied as part of endocrine signalling pathways in laboratory contexts.

Gonadotropin-releasing hormone, a hypothalamic peptide referenced in reproductive endocrinology research and distinct from GHRH; appears in kisspeptin and KISS1 receptor literature as a downstream signalling endpoint in laboratory models.

An alternative name for the KISS1 receptor (KISS1R), a G-protein-coupled receptor referenced in kisspeptin-family research literature.

The time required for a measurable quantity of a compound to reduce to half of its initial value within a specified system.

A peptide composed of seven amino acid residues.

High-performance liquid chromatography. A separation technique used to assess peptide identity and purity by comparing retention behaviour and detector response under defined conditions.

Research conducted outside a living organism, such as in cell culture or isolated biochemical systems.

Research conducted within a living organism. Used to describe the experimental context of a study and interpreted within that model.

A G-protein-coupled receptor referenced in reproductive endocrinology research, studied in relation to kisspeptin-family peptides in laboratory models.

Relating to a lamellipodium, a sheet-like cytoskeletal protrusion at the leading edge of migrating cells; referenced as a morphological descriptor in actin-related cellular migration assays.

A molecule that binds to a target such as a receptor or enzyme, often used to study pathway interactions.

A supplier-assigned identifier linking a sample to its production batch, used to align research observations with batch-level analytical context.

Freeze-dried form of a compound. Lyophilisation removes solvents to support stability during research storage.

Mitogen-activated protein kinase, a family of intracellular signalling kinases referenced as a downstream pathway marker in peptide receptor signalling research.

An analytical technique that ionises a sample and measures mass-to-charge ratios, used to confirm peptide identity by matching observed mass against the expected molecular weight.

A description of how a compound interacts with biological systems based on observations from research models.

The mass of one molecule of a compound, commonly expressed in daltons. Reported alongside structural information for identification.

The end of a peptide chain that carries a free amino group; conventionally written on the left when sequences are reported.

A peptide that participates in signalling within nervous-system research models, often studied through receptor and gene expression observations.

A ligand that triggers a receptor response below the maximum observed for full agonists in the same research model, used as a comparative descriptor in binding studies.

A short chain of amino acids connected by peptide bonds. Studied across biology, chemistry, and pharmacology.

A covalent amide linkage formed between the carboxyl group of one amino acid and the amino group of another, producing the backbone of peptides and proteins.

The study of how a compound is absorbed, distributed, metabolised, and eliminated within a given system or model.

Research conducted in laboratory or animal models prior to any clinical evaluation; observations remain bound to the model used.

An analytical descriptor reflecting the proportion of the intended compound present in a sample, typically reported alongside the method used to assess it.

A biological structure that recognises and binds specific ligands, often initiating downstream signalling responses.

A measure of how strongly a ligand associates with a specific receptor, reported as a research parameter when comparing ligand-receptor interactions in laboratory models.

The laboratory process of dissolving a lyophilised compound in an appropriate solvent for research use.

A positioning statement indicating that a material is intended for laboratory and educational contexts and is not approved for human consumption, therapeutic use, or clinical application.

An individual amino acid unit within a peptide chain, counted when describing sequence length such as a 10-residue peptide.

Common abbreviation for research-use-only.

The ordered list of amino acids forming a peptide, written in single- or three-letter codes.

A connected series of molecular events that transmit information within or between cells, often studied in response to specific compounds.

The ability of a compound to retain its identity, purity, and structure under defined storage and handling conditions.

A laboratory-prepared compound modelled on a reference peptide, typically modified to study how structural changes alter behaviour in a research system.

An enzyme associated with maintenance of telomere length at chromosome ends; referenced in cellular ageing marker research without implying outcomes beyond the model.

A peptide composed of four amino acid residues, often referenced in short-sequence research comparisons.

Research that examines how findings in laboratory models may relate to broader biological systems, while remaining a research activity.

A common counter-ion form of synthetic peptides produced via standard purification workflows; reported on certificates of analysis because the salt form contributes to total mass.

A peptide composed of three amino acid residues, sometimes studied as a coordination partner for metal ions in laboratory contexts.

A naturally occurring tetrapeptide associated with immunology research models and used as a reference structure for synthetic analogues.

Vascular endothelial growth factor receptor 2, a receptor tyrosine kinase referenced as a pathway marker in some preclinical peptide research models, including angiogenesis-oriented studies.